Searching across hundreds of databases

Our searching services are busy right now. Your search will reload in five seconds.

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

Preserved DNA Damage Checkpoint Pathway Protects against Complications in Long-Standing Type 1 Diabetes.

Cell metabolism | 2015

The mechanisms underlying the development of complications in type 1 diabetes (T1D) are poorly understood. Disease modeling of induced pluripotent stem cells (iPSCs) from patients with longstanding T1D (disease duration ≥ 50 years) with severe (Medalist +C) or absent to mild complications (Medalist -C) revealed impaired growth, reprogramming, and differentiation in Medalist +C. Genomics and proteomics analyses suggested differential regulation of DNA damage checkpoint proteins favoring protection from cellular apoptosis in Medalist -C. In silico analyses showed altered expression patterns of DNA damage checkpoint factors among the Medalist groups to be targets of miR200, whose expression was significantly elevated in Medalist +C serum. Notably, neurons differentiated from Medalist +C iPSCs exhibited enhanced susceptibility to genotoxic stress that worsened upon miR200 overexpression. Furthermore, knockdown of miR200 in Medalist +C fibroblasts and iPSCs rescued checkpoint protein expression and reduced DNA damage. We propose miR200-regulated DNA damage checkpoint pathway as a potential therapeutic target for treating complications of diabetes.

Pubmed ID: 26244933 RIS Download

Associated grants

  • Agency: NIGMS NIH HHS, United States
    Id: P41 GM103493
  • Agency: NIDDK NIH HHS, United States
    Id: K99DK090210
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK104167-01
  • Agency: NIDDK NIH HHS, United States
    Id: R00 DK090210
  • Agency: NIDDK NIH HHS, United States
    Id: K99 DK090210
  • Agency: NIDDK NIH HHS, United States
    Id: DP3 DK094333-01
  • Agency: NIDDK NIH HHS, United States
    Id: DP3 DK094333
  • Agency: NIH HHS, United States
    Id: DP2OD006668
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK036836
  • Agency: NCI NIH HHS, United States
    Id: R01 CA173712
  • Agency: Howard Hughes Medical Institute, United States
  • Agency: PHS HHS, United States
    Id: R01 103215
  • Agency: NIDDK NIH HHS, United States
    Id: R00DK090210
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK067536
  • Agency: NIDDK NIH HHS, United States
    Id: DK036836
  • Agency: NIDDK NIH HHS, United States
    Id: UC4 DK104167
  • Agency: NIH HHS, United States
    Id: DP2 OD006668
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK103215
  • Agency: NIDDK NIH HHS, United States
    Id: R01 DK67536

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Joslin Diabetes Center Bioinformatics and Biostatistics Core (tool)

RRID:SCR_015092

Core that offers support for data-driven projects related to basic, clinical and translational research, with a particular emphasis on diabetes. The core aims to ensure that researchers take advantage of the most modern and robust methods available in the field of Bioinformatics and Biostatistics.

View all literature mentions

Joslin Diabetes Center Flow Cytometry Core Facility (tool)

RRID:SCR_009878

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides cell sorting and flow cytometry services. Specific services include cell analysis, large object sorting,magnetic cell enrichment, and automatic cell counting.

View all literature mentions

Joslin Diabetes Center Advanced Microscopy Core Facility (tool)

RRID:SCR_009875

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides services for performing specific morphological procedures, providing training and access to equipment, maintaining the specialized microscopes, and giving advice and interpretation.

View all literature mentions

Joslin Diabetes Center Animal Physiology Core Facility (tool)

RRID:SCR_009876

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides technically advanced physiological evaluation of metabolism in diabetes, obesity, and their associated complications in rodents for DRC investigators and outside users. It also provides training of investigators and trainees in several physiological procedures.

View all literature mentions

Joslin Diabetes Center Advanced Genomics and Genetics Core Facility (tool)

RRID:SCR_009873

THIS RESOURCE IS NO LONGER IN SERVICE. Documented on October 27,2023. Core that provides services for genetic and genomic analysis, including DNA extraction from blood, access to DNA collections from the Core?s repository, SNP genotyping, and support for gene expression studies based on both high-density oligonucleotide arrays and real-time quantitative PCR.

View all literature mentions

Joslin Diabetes Center Induced Pluripotent Stem Cell Core (tool)

RRID:SCR_015120

Core that maintains a centralized facility for the generation and propagation of reprogrammed iPS cells for use in molecular and cellular pathologies underlying diabetes and its complications.

View all literature mentions

Joslin Diabetes Center Enrichment Core (tool)

RRID:SCR_015094

Six component core which facilitates the exchange of research information and discussions among investigators, fellows and students within the Joslin Diabetes Center, as well as between Joslin Staff and outside researchers with similar interests.

View all literature mentions